Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 149
Titolo Data di pubblicazione Autore(i) File
Rischio neoplastico post-trapianto 1-gen-2001 C., Bengala; Guarneri, Valentina; I., Pazzagli
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials 1-gen-2001 Conte, Pierfranco; Gennari, A; Guarneri, Valentina; Landucci, E; Donati, S; Salvadori, B; Bengala, C; Orlandini, C; Baldini, E.
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC) 1-gen-2001 C., Bengala; I., Pazzagli; F., Innocenti; S., Donati; C., Favre; M. C., Menconi; F., Greco; R., Danesi; C., Orlandini; Guarneri, Valentina; M., Del Tacca; Conte, Pierfranco
New combinations with epirubicin in advanced breast cancer. 1-gen-2001 Conte, Pierfranco; Gennari, A; Landucci, E; Guarneri, Valentina; Donati, S; Salvadori, B; Bengala, C; Orlandini, C.
Weekly docetaxel/paclitaxel in pretreated metalistic breast cancer 1-gen-2002 Gennari, A; Guarneri, Valentina; Landucci, E; Orlandini, C; Rondini, M; Salvadori, B; Ricci, S; Conte, Pierfranco
Outcomes of metastatic breast cancer patients older than 60 years treated with FEC or ET regimens: A retrospective analysis 1-gen-2003 A., Gennari; Guarneri, Valentina; C., Orlandini; B., Salvadori; S., Donati; M., Rondini; S., Ricci; E., Landucci; Conte, Pierfranco
High – dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study 1-gen-2003 C., Bengala; R., Danesi; Guarneri, Valentina; I., Pazzagli; S., Donati; C., Favre; S., Fogli; O., Biadi; F., Innocenti; M., DEL TACCA; M., Mariani; Conte, Pierfranco
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 1-gen-2004 Dominici, Massimo; Guarneri, Valentina; Cafarelli, Luigi; Conte, Pierfranco
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma - Results from the Gruppo Oncologico Nord Ovest randomized trial 1-gen-2004 Conte, Pierfranco; Guarneri, Valentina; P., Bruzzi; T., Prochilo; B., Salvadori; A., Bolognesi; D., Aldrighetti; M., Venturini; R., Rosso; S., Mammoliti; F., Carnino; P., Giannessi; M., Costantini; A., Moyano; E., Baldini
The curability of breast cancer and the treatment of advanced disease 1-gen-2004 Guarneri, Valentina; Conte, Pierfranco
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years 1-gen-2004 Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 1-gen-2004 Guarneri, Valentina; C., Bengala; C., Orlandini; A., Gennari; S., Donati; D., Campani; P., Collecchi; M., Maur; Conte, Pierfranco
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens 1-gen-2004 Conte, Pierfranco; Guarneri, Valentina
Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001 1-gen-2004 A., Gennari; Conte, Pierfranco; C., Orlandini; Guarneri, Valentina; R., Rosso; P., Bruzzi; for the North West Oncology Group, Gono
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 1-gen-2004 A., Gennari; P., Bruzzi; C., Orlandini; B., Salvadori; S., Donati; E., Landucci; Guarneri, Valentina; M., Rondini; S., Ricci; Conte, Pierfranco
In response to Body letter to the editor regarding "Safety of intravenous and oral Bisphosphonates and compliance with dosing regimens" 1-gen-2005 Conte, Pierfranco; Guarneri, Valentina
In response to Jackson letter to the editor regarding "Safety of intravenous and oral bisphosphonates and compliance with dosing regimens" 1-gen-2005 Conte, Pierfranco; Guarneri, Valentina
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 1-gen-2005 Conte, Pierfranco; S., Donati; A., Gennari; Guarneri, Valentina; C., Orlandini; M., Rondini; M., Roncella; L., Marini; P., Collecchi; P., Viacava; A. G., Naccarato; R., DEGLI ESPOSTI; S., Bonardi; A., Bottini; S., Saracchini; S., Tumolo; G., Gullo; A., Santoro; L., Crino
High dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transpalntation (EBMT) 1-gen-2005 C., Bengala; Guarneri, Valentina; J., Ledermann; G., Rosti; H., Wandt; Jp, Lotz; Jh, Cure; C., Orlandini; P., Ferrante; Conte, Pierfranco; T., Demirer
Renal safety and efficacy of intravenous bisphosphonates in patients with skeletal metastases treated for up to ten years 1-gen-2005 Guarneri, Valentina; S., Donati; M., Nicolini; S., Giovannelli; D'Amico, Roberto; Conte, Pierfranco
Mostrati risultati da 1 a 20 di 149
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile